Trial Profile
Multiple ascending doses of avagacestat in young and elderly volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Jan 2013
Price :
$35
*
At a glance
- Drugs Avagacestat (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 03 Jan 2013 New trial record